About this trial
The objective of this study is to evaluate whether twice-daily use of Tyrvaya improves contact lens comfort in contact lens wearers.
Eligibility criteria
Qualifiers
Adult male and female subjects of any race or ethnicity who are ≥18 years of age.
Best corrected CL visual acuity of 0.3 Logarithm of the Minimum Angle of Resolution (logMAR) or better in both eyes (Snellen equivalent 20/40).
Soft 1-day silicone hydrogel CL wearer (daily disposable only)
Contact Lens Dry Eye Questionnaire (CLDEQ)-8 scores (CLDEQ-8 scores ≥ 12).16
Disqualifiers
Any history of Tyrvaya use within six months of enrollment
Are currently an overnight CL wearer.
Are currently wearing rigid gas permeable CLs, scleral CL, hybrid CLs, or reusable soft CLs.
Have known systemic health conditions that are known to alter tear film physiology (e.g., primary and secondary Sjögren's syndrome).
Trial design
Treatments tested in this trial
- Tyrvaya
Treatment groups
Sponsors and collaborators
Ocular Aesthetics, LLC dba Ocular Clinical Trials
Lead sponsor
Viatris Inc.
Collaborator